Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125710483 | 12571048 | 3 | F | 20160616 | 20160825 | 20160719 | 20160901 | EXP | US-ASTRAZENECA-2016SE75848 | ASTRAZENECA | 24896.00 | DY | F | Y | 0.00000 | 20160901 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125710483 | 12571048 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5MCG, 2 PUFFS TWICE A DAY | U | U | 3001193C00 | 21929 | |||||||
| 125710483 | 12571048 | 2 | C | 16 TOTAL MEDICATIONS | 2 | 0 | |||||||||||||
| 125710483 | 12571048 | 3 | C | INSULIN | INSULIN NOS | 1 | 0 | ||||||||||||
| 125710483 | 12571048 | 4 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | AS NEEDED | 0 | ||||||||||
| 125710483 | 12571048 | 5 | C | FENTANYL. | FENTANYL | 1 | 0 | TRANSDERMAL PATCH | |||||||||||
| 125710483 | 12571048 | 6 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | 150 | MG | QD | |||||||||
| 125710483 | 12571048 | 7 | C | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Oral | 0 | 80 | MG | CAPSULE | BID | |||||||
| 125710483 | 12571048 | 8 | C | DURAGESIC | FENTANYL | 1 | 0 | 100 | MG | TRANSDERMAL PATCH | |||||||||
| 125710483 | 12571048 | 9 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | Oral | 0 | 50 | MG | TABLET | BID | |||||||
| 125710483 | 12571048 | 10 | C | NARCAN | NALOXONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125710483 | 12571048 | 11 | C | DIOVAN | VALSARTAN | 1 | Oral | 320/25 MG, 1 TAB P.O. EVERY DAY | 0 | TABLET | |||||||||
| 125710483 | 12571048 | 12 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 125710483 | 12571048 | 13 | C | BUSPAR | BUSPIRONE HYDROCHLORIDE | 1 | Oral | 0 | 15 | NG | TABLET | BID | |||||||
| 125710483 | 12571048 | 14 | C | LUVOX | FLUVOXAMINE MALEATE | 1 | Oral | 0 | 50 | MG | TABLET | QD | |||||||
| 125710483 | 12571048 | 15 | C | RESTORIL | TEMAZEPAM | 1 | Oral | 0 | 30 | MG | QD | ||||||||
| 125710483 | 12571048 | 16 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | 40 | MG | QD | |||||||||
| 125710483 | 12571048 | 17 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | BID | ||||||||
| 125710483 | 12571048 | 18 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 0 | 300 | MG | CAPSULE | TID | |||||||
| 125710483 | 12571048 | 19 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 125710483 | 12571048 | 20 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 0 | 30 | MG | Q12H | ||||||||
| 125710483 | 12571048 | 21 | C | OPANA | OXYMORPHONE HYDROCHLORIDE | 1 | Oral | 0 | 40 | MG | Q12H | ||||||||
| 125710483 | 12571048 | 22 | C | OLEPTRO | TRAZODONE HYDROCHLORIDE | 1 | Oral | 0 | 150 | MG | TABLET | QD | |||||||
| 125710483 | 12571048 | 23 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | 112 | UG | QD | ||||||||
| 125710483 | 12571048 | 24 | C | MYRBETRIQ | MIRABEGRON | 1 | Oral | 0 | 50 | MG | QD | ||||||||
| 125710483 | 12571048 | 25 | C | LINZESS | LINACLOTIDE | 1 | Oral | 290.0MG UNKNOWN | 0 | 290 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125710483 | 12571048 | 1 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125710483 | 12571048 | OT |
| 125710483 | 12571048 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125710483 | 12571048 | Arthralgia | |
| 125710483 | 12571048 | Back disorder | |
| 125710483 | 12571048 | Device malfunction | |
| 125710483 | 12571048 | Drug dose omission | |
| 125710483 | 12571048 | Dyspnoea exertional | |
| 125710483 | 12571048 | Fall | |
| 125710483 | 12571048 | Fibromyalgia | |
| 125710483 | 12571048 | Gait disturbance | |
| 125710483 | 12571048 | Incoherent | |
| 125710483 | 12571048 | Intentional product misuse | |
| 125710483 | 12571048 | Oxygen saturation decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125710483 | 12571048 | 1 | 20140613 | 0 |